Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Extracellular vesicles show promise for wound healing, but more research is needed to improve their stability and production.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

PRP therapy helps skin heal and improve by promoting cell growth and repair.

New understanding and treatments for hair loss are improving, but more research is needed.

Targeting the skin's endocannabinoid system could help treat skin disorders.

AGEs may cause hair loss by increasing inflammation in hair follicles.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

The new drug delivery system releases the drug better in sebum and targets follicles more effectively than the conventional cream.

Stem-cell therapy shows promise for skin conditions but needs more research.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

Experts advise using sunscreen and proper skin care before, during, and after procedures to speed healing, prevent complications, and reduce scarring.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

Antibiotics often cause skin reactions, making them a major health concern.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Early diagnosis and treatment of Hidradenitis Suppurativa are important to prevent serious physical and mental effects.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.